Neuroimmunomodulation in human autoimmune liver disease

[1]  C. V. van Nieuwkerk,et al.  Auto immune hepatitis. , 2016, World journal of gastroenterology.

[2]  Xiu‐da Shen,et al.  Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: Immunomodulation by the cAMP‐PKA pathway , 2013, Hepatology.

[3]  H. Friess,et al.  Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity , 2013, Acta Neuropathologica.

[4]  D. Marks,et al.  Perinatal Exposure to a High-Fat Diet Is Associated with Reduced Hepatic Sympathetic Innervation in One-Year Old Male Japanese Macaques , 2012, PloS one.

[5]  E. Fehér,et al.  Colocalization of substance P with tumor necrosis factor-α in the lymphocytes and mast cells in gastritis in experimental rats , 2011, Inflammation Research.

[6]  S. Lakhan,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Neuroinflammation in inflammatory bowel disease , 2010 .

[7]  M. Bronze,et al.  Hepatitis C Prevalence in Patients With Hepatocellular Carcinoma Without Cirrhosis , 2010, The American journal of the medical sciences.

[8]  D. Mann,et al.  NF-kappaB signalling: embracing complexity to achieve translation. , 2010, Journal of hepatology.

[9]  D. Abt,et al.  The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice. , 2009, Journal of hepatology.

[10]  R. Pierce,et al.  Indirect action of tumor necrosis factor‐alpha in liver injury during the CD8+ T cell response to an adeno‐associated virus vector in mice , 2009, Hepatology.

[11]  Ying Wang,et al.  Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury. , 2009, European journal of pharmacology.

[12]  I. Fabregat.  Dysregulation of apoptosis in hepatocellular carcinoma cells. , 2009, World journal of gastroenterology.

[13]  T. Miletić,et al.  The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age , 2008, Peptides.

[14]  E. Fehér,et al.  Correlation and Immunolocalization of Substance P Nerve Fibers and Activated Immune Cells in Human Chronic Gastritis , 2008, Anatomical record.

[15]  R. Jacobs,et al.  Neuropeptide Y receptor-specifically modulates human neutrophil function , 2008, Journal of Neuroimmunology.

[16]  H. El‐Serag.  Epidemiology of hepatocellular carcinoma in USA , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Herbert Herzog,et al.  NPY and receptors in immune and inflammatory diseases. , 2007, Current topics in medicinal chemistry.

[18]  P. Hegyi,et al.  The role of NF-κB activation in the pathogenesis of acute pancreatitis , 2007, Gut.

[19]  S. Hörsten,et al.  Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch , 2006, Peptides.

[20]  E. Fehér,et al.  Neuroimmune Link in the Mucosa of Chronic Gastritis with Helicobacter pylori Infection , 2006, Digestive Diseases and Sciences.

[21]  A. Benedetti,et al.  Nervous and Neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis. , 2006, World journal of gastroenterology.

[22]  A. Lohse,et al.  Immune-mediated liver injury. , 2005, Journal of hepatology.

[23]  M. Gershwin,et al.  T cell immunity in autoimmune hepatitis. , 2005, Autoimmunity reviews.

[24]  F. Shanahan,et al.  The role of substance P in inflammatory disease , 2004, Journal of cellular physiology.

[25]  G. Tiegs,et al.  Innervation of immune cells: evidence for neuroimmunomodulation in the liver. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[26]  K. Chung,et al.  Neuropeptide Y (NPY). , 2004, Pulmonary pharmacology & therapeutics.

[27]  T. Zelles,et al.  Morphological basis of sensory neuropathy and neuroimmunomodulation in minor salivary glands of patients with Sjögren's syndrome. , 2004, Archives of oral biology.

[28]  G. Tiegs,et al.  Neurokinin-1 Receptor Antagonists Protect Mice from CD95- and Tumor Necrosis Factor-α-Mediated Apoptotic Liver Damage , 2004, Journal of Pharmacology and Experimental Therapeutics.

[29]  N. Van Rooijen,et al.  NK Cells, but Not NKT Cells, Are Involved in Pseudomonas aeruginosa Exotoxin A-Induced Hepatotoxicity in Mice1 , 2004, The Journal of Immunology.

[30]  G. Tiegs,et al.  Close apposition of dynorphin-positive nerve fibres to lymphocytes in the liver suggests opioidergic neuroimmunomodulation , 2003, Histochemistry and Cell Biology.

[31]  A. Vollmar,et al.  Neurokinin-1 Receptor Antagonists CP-96,345 and L-733,060 Protect Mice from Cytokine-Mediated Liver Injury , 2003, Journal of Pharmacology and Experimental Therapeutics.

[32]  Lijun Li,et al.  Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? , 2003, Canadian journal of physiology and pharmacology.

[33]  T. Yamamura,et al.  Relevance of Neuropeptide Y for the neuroimmune crosstalk , 2003, Journal of Neuroimmunology.

[34]  J. Kirby,et al.  The immunology of primary biliary cirrhosis: the end of the beginning? , 2002, Clinical and experimental immunology.

[35]  W. Ho,et al.  HIV enhances substance P expression in human immune cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  R. Pabst,et al.  Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes , 2001, Journal of Neuroimmunology.

[37]  M. Fuente,et al.  Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions , 2001, Journal of Neuroimmunology.

[38]  G. Tiegs,et al.  Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by β-adrenergic stimulation , 1999, Journal of Neuroimmunology.

[39]  M. Stalp,et al.  Brain NPY Y1 receptors rapidly mediate the behavioral response to novelty and a compartment-specific modulation of granulocyte function in blood and spleen , 1998, Brain Research.

[40]  Ahmed,et al.  In Vitro Leishmania major Promastigote‐Induced Macrophage Migration is Modulated by Sensory and Autonomic Neuropeptides , 1998, Scandinavian journal of immunology.

[41]  Satoshi Obana,et al.  Differential Effects of Neuropeptides on Cytokine Production by Mouse Helper T Cell Subsets , 1998, Neuroimmunomodulation.

[42]  W. Neuhuber,et al.  Close anatomical relationships between nerve fibers and MHC class II-expressing dendritic cells in the rat liver and extrahepatic bile duct , 1998, Histochemistry and Cell Biology.

[43]  W. Ho,et al.  Substance P augments interleukin-10 and tumor necrosis factor-α release by human cord blood monocytes and macrophages , 1996, Journal of Neuroimmunology.

[44]  E. Theodorsson,et al.  Nerve growth factor stimulates production of neuropeptide Y in human lymphocytes , 1996, Neuroreport.

[45]  P. Howarth,et al.  Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. , 1995, American journal of respiratory cell and molecular biology.

[46]  R. Coppel,et al.  Primary Biliary Cirrhosis: The Molecule and the Mimic , 1995, Immunological reviews.

[47]  M. Palkovits,et al.  Immunohistochemical mapping of neuropeptides in the premamillary region of the hypothalamus in rats , 1995, Brain Research Reviews.

[48]  W. Ho,et al.  Substance P augments tumor necrosis factor release in human monocyte-derived macrophages. , 1994, Clinical and diagnostic laboratory immunology.

[49]  P. Villiger,et al.  Neuropeptide Y is an inducible gene in the human immune system , 1994, Journal of Neuroimmunology.

[50]  M. De la Fuente,et al.  Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. , 1993, Immunology.

[51]  Z. Żukowska-Grójec,et al.  Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. , 1993, The American journal of physiology.

[52]  J. J. van den Oord,et al.  Memory T cells represent the predominant lymphocyte subset in acute and chronic liver inflammation , 1991, Hepatology.

[53]  A. Ericsson,et al.  Detection of neuropeptide Y-like immunoreactivity and messenger RNA in rat platelets: the effects of vinblastine, reserpine, and dexamethasone on NPY expression in blood cells. , 1991, Experimental cell research.

[54]  M. Paglierani,et al.  Effect of sensory denervation with capsaicin on liver fibrosis induced by common bile duct ligation in rat. , 1990, Journal of hepatology.

[55]  H. Dienes,et al.  Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non‐A, Non‐B , 1987, Hepatology.

[56]  D. Larhammar,et al.  Detection of neuropeptide Y and its mRNA in megakaryocytes: enhanced levels in certain autoimmune mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Schemann,et al.  Mast cell-nerve axis with a focus on the human gut. , 2012, Biochimica et biophysica acta.

[58]  A. Czaja.  Autoimmune liver disease , 2007, Current opinion in gastroenterology.

[59]  J. Herkel,et al.  Immune-mediated liver injury. , 2005, Journal of hepatology.

[60]  H. Kawasaki,et al.  Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis , 1999, American Journal of Gastroenterology.

[61]  M. Delgado,et al.  Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system. , 1996, Advances in neuroimmunology.

[62]  高橋 識至.  Neuropeptide Y inhibits neurogenic inflammation in guinea-pig airways , 1995 .